The economic burden of Hepatitis B in Germany

European Journal of Epidemiology

Volumn 16, Issue 2, 2000, Pages 173-177

  Harbarth, Stephan ^c   Szucs, Thomas ^a   Berger, Karin ^b   Jilg, Wolfgang ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Forschungsgruppe Med Okonomie   (Germany)

^c NONE

Author keywords

Costs; Epidemiology; Germany; Hepatitis B

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; COHORT ANALYSIS; COST CONTROL; DIAGNOSTIC ACCURACY; EUROPE; GERMANY; HEALTH CARE COST; HEPATITIS B; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; SOCIOECONOMICS;

ADULT; COHORT STUDIES; COST OF ILLNESS; COST-BENEFIT ANALYSIS; DIRECT SERVICE COSTS; FEMALE; GERMANY; HEALTH CARE COSTS; HEPATITIS B; HEPATITIS B VACCINES; HUMANS; MALE;

EID: 0034077339     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007624415699     Document Type: Article

References (24)

1. Arnot R. The evolving efforts to control hepatitis B virus. Pediatr Infect Dis J 1998; 17 (7 Suppl): S26-S29.
2. Brechot C, Jaffredo F, Lagorce D, et al. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe. J Hepatol 1998; 29(2): 173-183.
3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337(24): 1733-1745.
4. Goudeau A. Epidemiology and eradication strategy for hepatitis B in Europe. European Regional Study Group. Vaccine 1990; 8 (Suppl): S113-S116.
5. Iwarson S, Jilg W, Stroffolini T. Substantial decline of notified hepatitis B in major parts of Europe after 1985. Scand J Infect Dis 1994; 26(1): 19-22.
6. Van Damme P, Vellinga A. Epidemiology of hepatitis B and C in Europe. Acta Gastroenterol Belg 1998; 61(2): 175-182.
7. Robert-Koch-Institut. Zur Situation bei ausgewählten meldepflichtigen Infektionserkrankungen im Jahr 1997. Teil 3: Virushepatitiden. Epidemiologisches Bulletin 1998; 13: 85-89.
8. Jefferson T, Demicheli V. Is vaccination against hepatitis B efficient? A review of world literature. Health Econ 1994; 3(1): 25-37.
9. Mortimer PP, Miller E. Commentary: Antenatal screening and targeting should be sufficient in some countries. Br Med J 1997; 314(7086): 1036-1037.
10. Goldberg D, McMenamin J. The United Kingdom's hepatitis B immunisation strategy - Where now? Commun Dis Public Health 1998; 1(2): 79-83.
11. Struve J, Giesecke J. Cost of acute hepatitis B infection in Swedish adults. Scand J Infect Dis 1993; 25(6): 693-697.
12. Van Damme P, Tormans G, Beutels P, van Doorslaer E. Hepatitis B prevention in Europe: A preliminary economic evaluation. Vaccine 1995; 13(Suppl 1): S54-S57.
13. Szucs TD, Schramm W. Economic evaluation of medical therapy - Methodological principles. Zentralbl Chir 1995; 120(8): 577-583.
14. Fleiss JL. An introduction to applied probability. In: Fleiss JL (ed.), Statistical methods for rates and proportions. 2 ed. vol. 1. New York, Chichester, Brisbane, Toronto: John Wiley & Sons, 1981: 1-19.
15. Lahaye D, Strauss P, Baleux C, van Ganse W. Cost-benefit analysis of hepatitis-B vaccination. Lancet 1987; 2(8556): 441-443.
16. Williams JR, Nokes DJ, Medley GF, Anderson RM. The transmission dynamics of hepatitis B in the UK: A mathematical model for evaluating costs and effectiveness of immunization programmes. Epidemiol Infect 1996; 116(1): 71-89.
17. Van Damme P, Kane M, Meheus A. Integration of hepatitis B vaccination into national immunisation programmes. Br Med J 1997; 314(7086): 1033-1036.
18. Szucs TD, Smala A, Berger K, Windorfer A. Economic evaluation of various hepatitis B immunisation strategies in children and adolescents. Med Klin 1998; 93(8): 468-477.
19. Adler MW, Belsey EM, McCutchan JA, Mindel A. Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. Br Med J (Clin Res Ed) 1983; 286(6378): 1621-1624.
20. Rivera F, Lissen E, Vazquez R, et al. Cost-benefit analysis of a program for vaccination against hepatitis B in health personnel of a hospital. Med Clin (Barc) 1984; 83(15): 611-614.
21. Lange W, Masihi KN. Epidemiology and economic importance of hepatitis B in the Federal Republic of Germany. Postgrad Med J 1987; 63 (Suppl 2): 21-26.
22. Szucs TD, Muller EI, Berger K. Cost structure of hepatitis B infection. Fortschr Med 1997; 115(4): 47-48.
23. Hoffmann V, Richter GM, Funk H, Otto G, Kauffmann GW. Liver transplantation and diagnostic radiology: socioeconomic aspects. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 1996; 165(2): 113-117.
24. Deutsches Kuratorium für Organspende, Jahresbericht 1998. Bad Honnef, Germany.